hjklj

Embed Size (px)

Citation preview

  • 7/30/2019 hjklj

    1/8

    AAA

    PPPRRROOOJJJEEECCCTTT RRREEEPPPOOORRRTTT OOONNN

    PPPRRROOODDDUUUCCCTTT PPPRRROOOMMMOOOTTTIIIOOONNN SSSTTTRRRAAATTTEEEGGGYYY OOOFFFLLLOOONNNNNNEEETTTTTT

    (ONDANSETERON INJECTION)

    Submitted in Partial Fulfillment

    of the Requirements for the Degree of

    BACHELOR OF PHARMACY

    by

    Vipul Kumar Jaiswal(Roll No. 0905650081)

    Under the Supervision of

    SUPERVISOR CO-SUPERVISOR

    Prof. (Dr.) Shailendra K. Saraf Mr. Aseem Tewari

    Director (Pharmacy) Senior Asst. Professor

    B.B.D.N.I.I.T., Lucknow B.B.D.N.I.I.T., Lucknow

    to the

    Faculty of Pharmacy

    BABU BANARSI DAS NORTHERN INDIA INSTITUTE OF

    TECHNOLOGY, LUCKNOW

    GAUTAM BUDDH TECHNICAL UNIVERSITY, LUCKNOW

    2012-2013

  • 7/30/2019 hjklj

    2/8

    DECLARATION

    I hereby declare that the studies described in this report entitled PRODUCT

    PROMOTION SRTATEGY OF BUDO-IN were carried out by me in the Faculty of

    Pharmacy, B.B.D.N.I.I.T, Lucknow under the supervision ofMr. Aseem Tewari . Further,

    this work has not been submitted in part or in full to obtain any other degree/ diploma.

    Place: LUCKNOW

    Date:

    ii

    JEETENDRA KUMAR MAURYA

    B.PHARM 4TH

    YEAR

    B.B.D.N.I.I.T. LUCKNOW

  • 7/30/2019 hjklj

    3/8

    CERTIFICATE

    Certified that Jeetendra Kumar Maurya (Roll no.0805650036) has carried

    out the project work in this project report entitled Project Promotion Strategy of

    BUDO-IN for the award of Bachelor of Pharmacy from Gautam Buddh Technical

    University, Lucknow under our supervision. This project report embodies result of

    original work, and studies are carried out by the student himself and the contents of the

    project report do not form the basis for the award of any other degree to the candidate or

    to anybody else from this or any other university/institution.

    Prof. (Dr.) Shailendra K. Saraf Mr. Aseem Tewari

    Director, Pharmacy Senior Asst. Professor,

    B.B.D.N.I.I.T, Lucknow B.B.D.N.I.I.T,Lucknow

    Date:-

    iii

  • 7/30/2019 hjklj

    4/8

    ACKNOWLEDGEMENT

    This project report could not have been completed without the tremendous help provided to me

    by my teachers.

    Firstly, I would like to thank Prof. (Dr.) Shailendra K. Saraf Director (Pharmacy) for his

    invaluable instructions and constructive comments. It was for his organizational skills that the whole

    project was so efficiently carried out.

    I am also grateful to my project guide Mr. Aseem Tewari for his help and support.

    I am thankful to all those known and unknown sources that helped me in completing such task.

    I express a word of thanks to my friends for their constant support, suggestions and

    encouragement during preparation of this project.

    Finally, I thank God for giving me the loving siblings and affectionate parents, who blessed me

    with everything all throughout my life. My gratitude to them cannot be expressed in words. To them

    I owe my wonderful today and a dream filled tomorrow.

    JEETENDA KUMAR MAYRYA

    B.B.D.N.I.I.T., LKO.

    iv

  • 7/30/2019 hjklj

    5/8

    Table of Content

    Declaration ii

    Certificate iii

    Acknowledgement iv

    List of Table v

    List of Figure vi

    CHAPTER 1:Introduction 1 - 9

    CHAPTER 2: Marketing Strategies 10 - 17

    CHAPTER 3: Promotional Strategies 18 - 31

    CHAPTER 4: Conclusion 32

    BIBLIOGRAPHY 33

  • 7/30/2019 hjklj

    6/8

    v

    List of Tables

    S. No. Particulars Table No. Page No.

    1. Drug Interactions of Budesonide 1.0 7

    2. Term and Definition Of marketingstrategy

    1.1 10 - 11

    3. Competitive products of Budesonide 1.2 17

  • 7/30/2019 hjklj

    7/8

    vi

    List of Figures

    S. No. Particulars Figure No. Page No.

    1. Molecular structure of Budesonide 1.0 1

    2. Mechanism of action ofGlucocorticoids (Budesonide)

    1.1 2

    3. Facters affecting of Marketing Strstegy

    1.2 10

    4. Normal and dieses condition of asthma 1.3 18

    5. Asthma Causing Agent 1.4 19

  • 7/30/2019 hjklj

    8/8

    vii